European Journal of Human Genetics

Papers
(The TQCC of European Journal of Human Genetics is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
A unique service: how an embedded psychology team can help patients and genetics clinicians within a clinical genetics service125
Hitting the heights with CiteScore100
Clinical implementation of polygenic risk scores97
Preferences for genetic testing among populations underrepresented in genomic research: a systematic review97
Commentary on Eichinger J, Zimmermann B, Elger B, McLennan S, Filges I, Koné I. 2023. ‘It’s a nightmare’: informed consent in paediatric genome-wide sequencing. A qualitative expert interview study fr92
Metaplastic breast cancer and BRCA1: first strong evidence of a link73
Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screening65
Utilization of automated cilia analysis to characterize novel INPP5E variants in patients with non-syndromic retinitis pigmentosa65
Germline NPAT inactivating variants as cause of hereditary colorectal cancer56
Ethical considerations for genetic research in low-income countries: perceptions of informed consent, data sharing, and expectations in Nicaragua52
The first genetically confirmed cohort of Facioscapulohumeral Muscular Dystrophy from Northern India48
Biallelic loss-of-function variants in ZNF142 are associated with a robust DNA methylation signature affecting a limited number of genomic loci46
The Young Geneticists Network and the ESHG-Young committee, a forward-looking international community45
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters43
View of healthcare professionals on ultra-rapid genome sequencing and its future implementation in clinical practice for critically ill children41
A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines41
“I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening41
Ethics in editorship: lessons from a major retraction incident41
Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study)41
Genotype of PAX2-related disorders correlates with kidney and ocular manifestations40
Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome40
Defining ethical criteria to guide the expanded use of Noninvasive Prenatal Screening (NIPS): Lessons about severity from preimplantation genetic testing36
Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series36
Identification of biallelic POLA2 variants in two families with an autosomal recessive telomere biology disorder34
Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells33
Panel testing for the molecular genetic diagnosis of congenital hypogonadotropic hypogonadism – a clinical perspective32
Direct-to-consumer genetic testing: an updated systematic review of healthcare professionals’ knowledge and views, and ethical and legal concerns32
Correction: A framework for evaluating long-term impact of newborn screening32
Börjeson–Forssman–Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families31
Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study30
Comment on Gustavson syndrome is caused by an in-frame deletion in RBMX associated with potentially disturbed SH3 domain interactions30
Investigation of a pathogenic inversion in UNC13D and comprehensive analysis of chromosomal inversions across diverse datasets30
Correction: Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes29
Genetic and allelic heterogeneity in 248 Indians with skeletal dysplasia28
30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes28
A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy27
Johann Gregor Mendel: the victory of statistics over human imagination26
Exome sequencing reveals broad genetic heterogeneity for neuromuscular disorders in consanguineous Pakistani Families26
Osteopathia striata with cranial sclerosis: a new case supporting the link with bilateral Wilms tumor26
Guidelines for genetic counselling supervision in Europe: a roadmap for ethical, effective, and reflective practice25
Identification and characterization of two DMD pedigrees with large inversion mutations based on a long-read sequencing pipeline24
Exploring the ethics of genetic prioritisation for COVID-19 vaccines24
Missense variants in homeobox domain of PBX1 cause coracoclavicular ankylosis24
Biallelic variants in the synaptic vesicle glycoprotein 2 A are associated with epileptic encephalopathy23
Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants23
An integrated multiomic approach as an excellent tool for the diagnosis of metabolic diseases: our first 3720 patients23
Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan23
Correction: Phenotypic subtypes of Xia-Gibbs syndrome: a latent class analysis22
Phenotypic subtypes of Xia-Gibbs syndrome: a latent class analysis22
Correction: Slowly progressive autosomal dominant Alport Syndrome due to COL4A3 splicing variant22
What’s new in genetics in June 2022?22
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics22
Penetrance and pleiotropy in ATXN2-related amyotrophic lateral sclerosis21
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan21
Solving medical mysteries with genomics21
Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia21
Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study20
Abstracts from the 57th European Society of Human Genetics (ESHG) Conference: Hybrid Posters20
Should testing for mosaic genome-wide paternal uniparental disomy in Beckwith-Wiedemann spectrum (BWSp) be implemented in diagnostic testing?20
Demolishing the silo: towards team-based genomics in primary care20
Editorial Déjà Vu: This time, it’s actually ‘what’s new in EJHG in May 2025?’20
Koban culture genome-wide and archeological data open the bridge between Bronze and Iron Ages in the North Caucasus19
POLD3 haploinsufficiency is linked to non-syndromic sensorineural adult-onset progressive hearing and balance impairments19
New Insight into the genotype-phenotype correlation of PTH1R variants and primary failure of tooth eruption on an Italian Cohort19
Comparing 2D and 3D representations for face-based genetic syndrome diagnosis18
Recommendations for whole genome sequencing in diagnostics for rare diseases18
Importance of critical thinking to understand ChatGPT18
Confirmation and expansion of the phenotype of the TCEAL1-related neurodevelopmental disorder18
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability18
Correction: Genetic discrimination still casts a large shadow in 202218
Concerns about the consequences of cancer predisposition and relationships with quality of life in young adults with Li-Fraumeni syndrome18
Regional autozygosity association with albumin-to-creatinine ratio reveals a novel FTO region in an Indigenous Australian population17
Episignature analysis of moderate effects and mosaics17
Exome sequencing as first-tier genetic testing in infantile-onset pharmacoresistant epilepsy: diagnostic yield and treatment impact17
Endometriosis - on the intersection of modern environmental pollutants and ancient genetic regulatory variants17
Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy17
Comment on Informing relatives of their genetic risk: an examination of the Belgian context17
Prenatal Genome-Wide Sequencing analysis (Exome or Genome) in detecting pathogenic Single Nucleotide Variants in fetal Central Nervous System Anomalies: systematic review and meta-analysis17
Expanding the understanding of DDX3X-related neurodevelopmental disorder in males17
Attitudes of professional stakeholders towards implementation of reproductive genetic carrier screening: a systematic review17
A rare genotype of biallelic mosaic variants in BCOR gene causing a bilateral ocular anterior segment dysgenesis and cataracts16
Highly variable hearing loss due to POU4F3 (c.37del) is revealed by longitudinal, frequency specific analyses16
“Hypothesis: Patient with possible disturbance in programmed cell death”: further insights in pathogenicity and clinical features of Fraser syndrome16
A biallelic variant of DCAF13 implicated in a neuromuscular disorder in humans16
Determining a role for Patient and Public Involvement and Engagement (PPIE) in genomic data governance for cancer care16
Spring in EJHG16
Studying ultra-rare variants in STX1A uncovers a novel neurodevelopmental disorder16
Pathogenic cryptic variants detectable through exome data reanalysis significantly increase the diagnostic yield in Joubert syndrome15
CHAMP1-related disorders: pathomechanisms triggered by different genomic alterations define distinct nosological categories15
A second hotspot for pathogenic exon-skipping variants in CDC4515
Correction: Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations15
Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations15
Quality of life, illness perceptions, and parental lived experiences in TANGO2-related metabolic encephalopathy and arrhythmias15
What does a consent conversation for whole genome sequencing look like in the NHS Genomic Medicine Service? An observational study15
MINDDS-connect: a federated data platform integrating biobanks for meta cohort building and analysis15
Correction: Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study15
Analysis of large-language model versus human performance for genetics questions15
Constitutional copy number amplifications: rare or under-evaluated? Revisiting a 25-year-old cold case15
A homozygous frameshift variant in the CILK1 gene causes cranioectodermal dysplasia15
Correction: A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells15
A yeast based assay establishes the pathogenicity of novel missense ACTA2 variants associated with aortic aneurysms15
Assessing the unmet needs of genomic testing in Australia: a geospatial exploration15
The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases14
The efficacy of genetic counselling for familial colorectal cancer. A randomised clinical trial14
Role of ZFHX4 in orofacial clefting based on human genetic data and zebrafish models14
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition14
Consanguinity and willingness to perform premarital genetic screening in Sudan14
Assessing the digenic model in rare disorders using population sequencing data14
A tiered strategy to identify relevant genetic variants in familial pulmonary fibrosis: a proof of concept for the clinical practice14
Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies14
New year, new issue14
Craniofrontonasal syndrome in a patient with an inv(X)(p22.2q13.1), separating EFNB1 from its enhancer14
Assessing the contribution of genetic nurture to refractive error14
To sign or not to sign: Is this still the question?14
The natural history of adults with Rubinstein-Taybi syndrome: a families-reported experience14
Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements14
Negotiating severity behind the scenes: prenatal testing in Germany14
Reassessment of variants of uncertain significance in tumor suppressor genes using new ClinGen PP1/PP4 criteria guidance13
Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG13
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot13
A family with ulcerative colitis maps to 7p21.1 and comprises a region with regulatory activity for the aryl hydrocarbon receptor gene13
Molecular investigation in individuals with orofacial clefts and microphthalmia-anophthalmia-coloboma spectrum13
What is health and what do we mean when we say an intervention improves health?13
Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability13
Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditions12
Germline pathogenic variants in HNRNPU are associated with alterations in blood methylome12
Diagnostic outcome of pro bono neurogenetic diagnostic service in Sri Lanka: A wealth creation12
Knowledge, attitudes and demand toward cardiovascular polygenic risk testing in clinical practice: cross-sectional survey of patients12
Negotiating ‘severity’ in plain sight12
Machine learning predicts distinct biotypes of amyotrophic lateral sclerosis12
Ten years of dynamic consent in the CHRIS study: informed consent as a dynamic process12
Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update12
Genome sequencing enables diagnosis and treatment of SLC5A6 neuropathy12
The Spanish Polygenic Score reference distribution: a resource for personalized medicine12
Recessive variants in CACNB1: a new culprit in congenital myopathy. Expanding the genetic causes of excitation–contraction coupling disorders12
Refining clinically relevant parameters for mis-splicing risk in shortened introns with donor-to-branchpoint space constraint12
Clinical and genetic analysis further delineates the phenotypic spectrum of ALDH1A3-related anophthalmia and microphthalmia12
‘Diagnostic shock’: the impact of results from ultrarapid genomic sequencing of critically unwell children on aspects of family functioning12
Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review12
Risk perception and intended behavior change after uninformative genetic results for adult-onset hereditary conditions in unselected patients12
Correction to: Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomaly12
Phenotypic compatibility and specificity in genomic variant classification12
Novel PUF60 variant suggesting an interaction between Verheij and Cornelia de Lange syndrome: phenotype description and review of the literature12
A tool for translating polygenic scores onto the absolute scale using summary statistics12
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres11
Expanding the phenotypic spectrum of LIG4 pathogenic variations: neuro-histopathological description of 4 fetuses with stenosis of the aqueduct11
An encounter with the mild side of LARS2-associated Perrault syndrome and its implications on the diagnostic odyssey11
Microsatellite instability in gastrointestinal cancers11
Structural variation in nebulin and its impact on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions11
“I am not a number!” Opinions and preferences of people with intellectual disability about genetic healthcare11
Estimating the use of biological samples in Finnish biobanks and hospital collections11
Mild phenotypes in patients with different deletions in the 3′ enhancer region of SHOX11
Early illustrations of the importance of systematic phenotyping11
Returning individual research results in international direct-to-participant genomic research: results from a 31-country study11
The cause of Jones syndrome put to REST: a mutation in the REST gene causes gingival fibromatosis and hearing loss11
Becoming agents for genomic change: genetic counsellors’ views of patient care and implementation influences when genomics is mainstreamed11
Global trends and themes in genetic counseling research11
Societal implications of expanded universal carrier screening: a scoping review11
Leave no one behind: inclusion of alpha-1 antitrypsin deficiency patients in COVID-19 vaccine trials11
Novel phenotype of SIN3A-related disorder diagnosed in adulthood with multi-system involvement11
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Oral Presentations11
Developing genetic literacy in high school students with intellectual disability: Teachers’ experiences and perspectives11
De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from India10
Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene10
Knowledge, attitudes and decision regret: a longitudinal survey study of participants offered genome sequencing in the 100,000 Genomes Project10
Loss of function of ADNP by an intragenic inversion10
GWAS of lipids in Greenlanders finds association signals shared with Europeans and reveals an independent PCSK9 association signal10
The congenital hearing phenotype in GJB2 in Queensland, Australia: V37I and mild hearing loss predominates10
GLA insufficiency should not be called Fabry disease10
Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.3210
Combined approaches, including long-read sequencing, address the diagnostic challenge of HYDIN in primary ciliary dyskinesia10
Clinical genomics testing: mainstreaming and globalising10
From screening to strategy: Clinical implications of COL4A3/COL4A4 variants found in reproductive genetic testing10
Comment on Future trends in clinical genetic and genomic services by Borle et al.10
Improving diagnosis of mitochondrial fatty-acid oxidation disorders10
POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program10
Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members10
Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge10
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women10
Uncertainty, ethics, and progress in genomic medicine10
Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis10
Somatic and germinal mosaicism in a Han Chinese family with laminopathies9
An analysis of genetically regulated gene expression and the role of co-expression networks across 16 psychiatric and substance use phenotypes9
The utility of population level genomic research9
Interrupted CTG repeats in the 37–43 units size range in the 3ʹUTR of DMPK are common alleles9
Reassessment of FBN1 variants of uncertain significance using updated ClinGen guidance for PP1/BS4 and PP4 criteria9
Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield9
Biallelic variants in RYR1 and STAC3 are predominant causes of King-Denborough Syndrome in an African cohort9
Genetic basis of osteogenesis imperfecta from a single tertiary centre in South Africa9
Predictive genetic testing for Motor neuron disease: time for a guideline?9
ParseCNV2: efficient sequencing tool for copy number variation genome-wide association studies9
Host genetic basis of COVID-19: from methodologies to genes9
Are employees ready to engage in genetic cancer risk assessment in the workplace setting?9
Biallelic variants in CCN2 underlie an autosomal recessive kyphomelic dysplasia9
Summer reading 2025 in EJHG9
Down syndrome screening and diagnosis practices in Europe, United States, Australia, and New Zealand from 1990–20219
Opportunities and challenges for paediatricians requesting funded genomic tests for children9
Workshop report: the clinical application of data from multiplex assays of variant effect (MAVEs), 12 July 20239
Should non-invasive prenatal testing (NIPT) be used for fetal sex determination? Perspectives and experiences of healthcare professionals9
Consent for genomic sequencing: a conversation, not just a form9
Recessive variants in WSB2 encoding a substrate receptor of E3 ubiquitin ligase underlie a neurodevelopmental syndrome9
Incorporating biobanking into the future of healthcare: exploring patient and healthcare worker perspectives at a Canadian tertiary academic hospital9
Scientific refutation of ESHG statement on embryo selection9
Genomic technologies identify milder presentations of Mendelian disease9
Genetic diagnosis for rare diseases in the Dutch Caribbean: a qualitative study on the experiences and associated needs of parents9
The stepwise process of integrating a genetic counsellor into primary care9
Genomic medicine in neonatal care: progress and challenges9
Emerging cancer risks in BRCA2 pathogenic germline variant carriers9
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection9
Novel HSPB8 mutations in severe early-onset myopathy with involvement of respiratory and cardiac muscles cause proteostasis defects in cell models9
Bi-allelic MYMX variants cause a syndromic congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism8
Beyond the hype: a comprehensive critique of ChatGPT’s applicability in genetics8
Correction to: The stepwise process of integrating a genetic counsellor into primary care8
Research participants: critical friends, agents for change8
Two for the heart: Dutch Pharmacogenetic Working Group prescribing guidance on statins and sulfonylureas to reduce cardiometabolic risk8
WDR45-related encephalopathy mimicking Leigh syndrome associated with complex I deficiency: a case report8
CDK13-related disorder: a deep characterization of speech and language abilities and addition of 33 novel cases8
Singleton exome sequencing of 90 fetuses with ultrasound anomalies revealing novel disease-causing variants and genotype–phenotype correlations8
A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells8
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer8
Impact of rapid genomic testing on clinical outcomes of acutely unwell children presenting with severe epilepsy8
A new impact factor for EJHG in 20228
What’s new in EJHG in June 2024?8
Rare-variant association analysis reveals known and new age-related hearing loss genes8
Autistic perspectives on the moral and ethical considerations of genetic testing for autism8
Biallelic SH2B3 germline variants are associated with a neonatal myeloproliferative disease and multisystemic involvement8
Surveillance of multiple congenital anomalies; searching for new associations8
LARS2 variants can present as premature ovarian insufficiency in the absence of overt hearing loss8
Reanalysis of clinical exome identifies the second variant in two individuals with recessive disorders8
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers8
DNA methylation episignature for Smith-Magenis and Potocki-Lupski syndromes: a mirror perspective8
STRavinsky STR database and PGTailor PGT tool demonstrate superiority of CHM13-T2T over hg38 and hg19 for STR-based applications8
KiT-GENIE, the French genetic biobank of kidney transplantation8
GenCOLT: a multicenter European biobank for investigating genome-wide determinants of lung transplant outcomes8
A novel in-frame GFAP p.E138_L148del mutation in Type II Alexander disease with atypical phenotypes8
Validity of European-centric cardiometabolic polygenic scores in multi-ancestry populations8
Polygenic risk modeling for prediction of epithelial ovarian cancer risk8
Expanding the speech and language phenotype in Koolen-de Vries syndrome: late onset and periodic stuttering a novel feature8
Contributing to the on-going debate around the clinical application of preimplantation embryo selection based on polygenic risk scores (PGT-P)8
EMD missense variant causes X-linked isolated dilated cardiomyopathy with myocardial emerin deficiency8
Genetic counselling and testing for neurodegenerative disorders using a proposed standard of practice for ALS/MND: diagnostic testing comes first8
Reevaluating ‘seriousness’ in genetic conditions: balancing clinical criteria and lived experiences8
PKD1 5’UTR variants are a rare cause of disease in ADPKD and suggest a new focus for therapeutic development8
MYBPC3 c.2309-2A>G: exploring a founder variant in Italian hypertrophic cardiomyopathy patients7
Tools used to appraise the quality of studies included in systematic reviews and meta-analyses in human genetics: a systematic review7
Expanding the phenotype associated with biallelic SLC20A2 variants7
Somatic genetic variation in healthy tissue and non-cancer diseases7
Predicting the phenotype of Pompe Disease from features of GAA variants7
Why don’t we all use genomic testing?7
Good quality practices for artificial intelligence in genetics7
0.6564929485321